newsfilter
← Latest News
Business Wire·

Tivic Reports Second Quarter 2025 Financial Results

Company advances its TLR5 agonist program and prepares to report VNS clinical data Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced financial results for the